Synovics Pharmaceuticals, Inc. (SYVC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 13, 2025
Synovics Pharmaceuticals Revenue
Synovics Pharmaceuticals had revenue of $1.58M in the quarter ending July 31, 2009, a decrease of -79.54%. This brings the company's revenue in the last twelve months to $19.09M, down -18.48% year-over-year. In the fiscal year ending October 31, 2008, Synovics Pharmaceuticals had annual revenue of $25.96M with 10.62% growth.
Revenue (ttm)
19.09M
Revenue Growth
-18.48%
P/S Ratio
0.00
Revenue / Employee
123.17K
Employees
155
Market Cap
3.65K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2008 | 25.96M | 2.49M | 10.62% |
| Oct 31, 2007 | 23.47M | 12.95M | 123.14% |
| Oct 31, 2006 | 10.52M | 10.51M | 128,274.00% |
| Oct 31, 2005 | 8.19K | -90.58K | -91.71% |
| Oct 31, 2004 | 98.77K | 66.79K | 208.86% |
| Oct 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 1999 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ONE Bio | 53.91M |
| Kaleido Biosciences | 1.10M |
| MultiCell Technologies | 805.24K |
| Syros Pharmaceuticals | 386.00K |
| MetaStat | 23.30K |